12 Health Care Stocks Moving In Thursday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Thursday's pre-market session, several healthcare stocks experienced significant movements. Onconetix (ONCO) saw a substantial increase of 152.6%, while Astria Therapeutics (ATXS) led the losers with a 23.4% decline. Notably, Humana (HUM) also fell by 14.76% as their Q4 earnings were released.
January 25, 2024 | 1:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Onconetix stock soared by 152.6% to $0.37 with a market cap of $8.2 million.
The significant pre-market increase in ONCO's stock price suggests a strong positive sentiment which could lead to a short-term upward trend.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Astria Therapeutics stock declined by 23.4% to $6.51 with a market cap of $267.1 million.
The notable pre-market decline in ATXS's stock price indicates negative investor sentiment, likely leading to a short-term decrease in stock value.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Humana stock fell by 14.76% to $343.02, with a market cap of $42.2 billion, coinciding with the release of their Q4 earnings.
The drop in HUM's stock price following the Q4 earnings release suggests the results may not have met investor expectations, potentially leading to a short-term negative impact.
CONFIDENCE 90
IMPORTANCE 95
RELEVANCE 100